Oxford Immunotec announces New England Journal of Medicine publication
Oxford Immunotec announced the NEJM has published an article on a three-year clinical trial completed by Oxford Immunotec's Imugen division, and the American Red Cross to evaluate a serology and Nucleic acid Amplification Test testing regime for Babesia in blood screening. December 08, 2016